Bryan Wahl, General Counsel of Tarsus Pharmaceuticals ($TARS), sold shares on the open market three times in the past year for a total of $463,766. His most recent sale occurred on March 20, 2025. These insider sales rank 6,625th among 11,678 individuals in our database, well below the average of $8.6 million across 6.4 transactions. Wahl made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 4084 | $69.42 | 72,315.0000 | 42,607,717 | 5.35% | 0.01% |
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 4231 | $67.00 | 63,959.0000 | 42,607,717 | 6.20% | 0.01% |
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 4125 | $68.71 | 68,190.0000 | 42,607,717 | 5.70% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 7176 | $0.00 | 14,351.0000 | 42,607,717 | 33.33% | 0.02% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 5022 | $0.00 | 15,067.0000 | 42,607,717 | 25.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Common Stock | 24236 | $0.00 | 76,399.0000 | 42,607,717 | 46.46% | 0.06% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 4790 | $0.00 | 0.0000 | 42,607,717 | 100.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 7248 | $0.00 | 7,249.0000 | 42,607,717 | 50.00% | 0.02% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Restricted Stock Units | 17161 | $0.00 | 17,161.0000 | 42,607,717 | 9999.99% | 0.04% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Stock Option (right to buy) | 27310 | $0.00 | 27,310.0000 | 42,607,717 | 9999.99% | 0.06% |
| March 19, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 3261 | $47.40 | 54,796.0000 | 37,604,538 | 5.62% | 0.01% |
| March 20, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 3084 | $50.11 | 51,712.0000 | 37,604,538 | 5.63% | 0.01% |
| March 18, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 3341 | $46.29 | 58,057.0000 | 37,604,538 | 5.44% | 0.01% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 7248 | $0.00 | 14,497.0000 | 37,604,538 | 33.33% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 7175 | $0.00 | 21,527.0000 | 37,604,538 | 25.00% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Common Stock | 19213 | $0.00 | 61,398.0000 | 37,604,538 | 45.54% | 0.05% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 4790 | $0.00 | 4,790.0000 | 37,604,538 | 50.00% | 0.01% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Stock Option (right to buy) | 30628 | $0.00 | 30,628.0000 | 37,604,538 | 9999.99% | 0.08% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Restricted Stock Units | 20089 | $0.00 | 20,089.0000 | 37,604,538 | 9999.99% | 0.05% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 7248 | $0.00 | 21,745.0000 | 29,383,276 | 25.00% | 0.02% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Common Stock | 12038 | $0.00 | 45,387.0000 | 29,383,276 | 36.10% | 0.04% |
| March 18, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 4436 | $30.60 | 40,951.0000 | 29,383,276 | 9.77% | 0.02% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 4790 | $0.00 | 9,580.0000 | 29,383,276 | 33.33% | 0.02% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Stock Option (right to buy) | 42500 | $0.00 | 42,500.0000 | 29,383,276 | 9999.99% | 0.14% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Restricted Stock Units | 28702 | $0.00 | 28,702.0000 | 29,383,276 | 9999.99% | 0.10% |
| Nov. 29, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 23920 | $0.00 | 0.0000 | 24,619,700 | 100.00% | 0.10% |
| Nov. 29, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Common Stock | 23920 | $0.00 | 40,322.0000 | 24,619,700 | 145.84% | 0.10% |
| Nov. 30, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 8356 | $16.31 | 31,966.0000 | 24,619,700 | 20.72% | 0.03% |
| March 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 371 | $12.15 | 16,402.0000 | 24,619,700 | 2.21% | 0.00% |
| March 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 357 | $12.64 | 16,773.0000 | 24,619,700 | 2.08% | 0.00% |
| March 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 350 | $12.89 | 17,130.0000 | 24,619,700 | 2.00% | 0.00% |
| March 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 339 | $13.28 | 17,837.0000 | 24,619,700 | 1.87% | 0.00% |
| March 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 357 | $12.61 | 17,480.0000 | 24,619,700 | 2.00% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Restricted Stock Units | 4790 | $0.00 | 14,370.0000 | 24,619,700 | 25.00% | 0.02% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | M | Common Stock | 4790 | $0.00 | 18,513.0000 | 24,619,700 | 34.90% | 0.02% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | S | Common Stock | 337 | $13.43 | 18,176.0000 | 24,619,700 | 1.82% | 0.00% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Stock Option (right to buy) | 42802 | $0.00 | 42,802.0000 | 24,619,700 | 9999.99% | 0.17% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Wahl Bryan | General Counsel | A | Restricted Stock Units | 28993 | $0.00 | 28,993.0000 | 24,619,700 | 9999.99% | 0.12% |